MedTrace Logo

Pleural Disease: Phenotypes, Diagnostic Yield and Outcomes

NCT03922841 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2021-10-01

No results posted yet for this study

Summary

Pleural disease i.e. with effusions or pneumothorax have a high disease burden to patients. This is because most patients require diagnostic and therapeutic interventions in the form of drainage and biopsies. With increasing age, the incidence of pleural disease is likely to rise with concomitant rise in pulmonary malignancy and infection.

The impact of pleural disease, especially ambulatory drainage depends not only on patient factors such as effusion size, cardiopulmonary co-morbidities and underlying aetiology. It also depends on socioeconomic factors such as ability to afford ambulatory equipment (which is not covered by Medisave), availability of care-givers and coping mechanisms.

To phenotype patients presenting to Singapore General Hospital with pleural disease and evaluate impact on outcomes of pleural interventions

This study will collect existing or prospective data that is part of standard clinical care

* Source of the data: electronic medical record of patients (ambulatory and inpatient)
* Data will be collected prospectively.

Conditions

  • Pleural Diseases

Interventions

OTHER

Pleural disease management

History, physical examination, pleural drainage, lab/radiographic investigations

Sponsors & Collaborators

  • Singapore General Hospital

    lead OTHER

Principal Investigators

  • Devanand Anantham, MRCP · Singhealth Foundation

Eligibility

Min Age
16 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-09
Primary Completion
2021-01-01
Completion
2021-01-01

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03922841 on ClinicalTrials.gov